Duratuss AC
NDC 50991-540, Codeine Phosphate, Dexbrompheniramine Maleate, liquid, from Poly Pharmaceuticals, Inc..
- Product NDC
- 50991-540
- Status
- Listed
- Labeler
- Poly Pharmaceuticals, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/50991-540 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CODEINE PHOSPHATE10 mg/5mL
- DEXBROMPHENIRAMINE MALEATE1 mg/5mL
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50991-540-16 | 50991054016 | 473 mL in 1 BOTTLE (50991-540-16) |
| 50991-540-20 | 50991054020 | 20 mL in 1 BOTTLE (50991-540-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50991-540 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50991-540 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50991-540. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.